| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/DMD.30.4.457 |
| P698 | PubMed publication ID | 11901101 |
| P50 | author | Patrick J Sinko | Q57069206 |
| P2093 | author name string | Ailan Guo | |
| Peidi Hu | |||
| William Marinaro | |||
| P433 | issue | 4 | |
| P921 | main subject | overexpression | Q61643320 |
| etoposide | Q418817 | ||
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 457-463 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Drug Metabolism and Disposition | Q1261140 |
| P1476 | title | Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT) | |
| P478 | volume | 30 |
| Q45153266 | A "drug cocktail" delivered by microspheres for the local treatment of rat glioblastoma |
| Q42846693 | An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1. |
| Q39527868 | Calcein assay: a high-throughput method to assess P-gp inhibition. |
| Q30234940 | Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions. |
| Q36553783 | Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP. |
| Q39657896 | Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). |
| Q33995372 | Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it? |
| Q36543091 | Drug-drug interactions involving membrane transporters in the human kidney |
| Q42429561 | Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir |
| Q36004628 | Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies |
| Q39665168 | Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen |
| Q39472771 | Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells |
| Q33614494 | Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance |
| Q38051447 | Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions |
| Q46897790 | Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM. |
| Q36271954 | Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application |
| Q34459467 | NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells |
| Q36613874 | Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions |
| Q35771512 | Pharmacokinetic optimisation of treatment with oral etoposide. |
| Q44797030 | Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children. |
| Q45792529 | Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II. |
| Q34983639 | Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition |
| Q46484127 | Species difference in intestinal absorption mechanism of etoposide and digoxin between cynomolgus monkey and rat. |
| Q45220374 | Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells. |
| Q36609743 | Strategies to assess the drug interaction potential in translational medicine |
| Q38853359 | The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1. |
| Q34227679 | The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells. |
| Q38478413 | Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions |
| Q35868689 | Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice |
| Q28473683 | Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II |
| Q39416207 | Vosaroxin: a new valuable tool with the potential to replace anthracyclines in the treatment of AML? |
Search more.